Mirtazapine Tablet, Film Coated
Product Images NDC 71610-853

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71610-853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0853 60)

Mirtazapine USP 15 mg film-coated tablets in a bottle containing 90 tablets. The label includes storage instructions to keep between 20-25 degrees Celsius and out of reach of children. Manufactured by Prasco, LLC in Mason, OH, and packaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The product is for prescription use only, with NDC 71610-853-60.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Mirtazapine Tablets Usp 1)

Chemical structure diagram of mirtazapine. The illustration depicts the molecular structure with interconnected rings and labeled atoms, including nitrogen and carbon groups, consistent with mirtazapine's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.